Literature DB >> 2451442

Clinical applications of the immunohistochemistry of filamentous proteins.

H Battifora1.   

Abstract

The past few years have seen great progress in our knowledge of the biology and the chemistry of intermediate filaments and other filamentous proteins. This has translated into the development of antibodies that, together with new, highly sensitive immunohistochemical methods, have resulted in much improved diagnostic accuracy. New, more specific antibodies to these and other useful markers will no doubt be developed in the future. More efficient techniques for screening of these antibodies will contribute to their rapid evaluation. Libraries of antibodies that identify subclasses of filamentous proteins will very likely become routine tools in the histopathology laboratory in the near future. Moreover, as the chemical structure of the proteins that form the complex family of intermediate filaments becomes better understood, and the DNA sequences coding them are determined, it may become feasible to use molecular genetic approaches such as in situ hybridization to gain further insight into neoplastic processes of unclear histogenesis and to develop more precise diagnostic and taxonomic instruments. Nevertheless, it is worth repeating that application of these molecular tools cannot be successful unless it is backed by a thorough understanding of the principles of histopathologic diagnosis that have been painstakingly established by generations of anatomic pathologists.

Mesh:

Substances:

Year:  1988        PMID: 2451442

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  5 in total

1.  Cytokeratin-immunoreactive cells of human lymph nodes and spleen in normal and pathological conditions. An immunocytochemical study.

Authors:  C Doglioni; P Dell'Orto; G Zanetti; P Iuzzolino; G Coggi; G Viale
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

2.  Cytokeratin intermediate filament expression in benign and malignant breast disease.

Authors:  M Heatley; P Maxwell; C Whiteside; P Toner
Journal:  J Clin Pathol       Date:  1995-01       Impact factor: 3.411

3.  Characterization of a dermal derived malignant mesenchymal tumor arising in ultraviolet irradiated mice.

Authors:  R G Phelps; L E Bernstein; N Harpaz; R E Gordon; F A Cruickshank; E Schwartz
Journal:  Am J Pathol       Date:  1989-07       Impact factor: 4.307

4.  Differential expression of neurofilament triplet proteins in carcinoid tumours: an immunohistochemical study.

Authors:  R Astarloa; F Sánchez-Franco; L Cacicedo; M García-Villanueva
Journal:  Br J Cancer       Date:  1991-05       Impact factor: 7.640

5.  Circulating tumor cells expressing cancer stem cell marker CD44 as a diagnostic biomarker in patients with gastric cancer.

Authors:  Toru Watanabe; Tomoyuki Okumura; Katsuhisa Hirano; Tetsuji Yamaguchi; Shinichi Sekine; Takuya Nagata; Kazuhiro Tsukada
Journal:  Oncol Lett       Date:  2016-11-24       Impact factor: 2.967

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.